نتائج البحث

Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis.

• Authors : Charriez, C.M.; Zhang, S.; de Oliveira, CHMC

Subjects: Humans; Eosinophilic Esophagitis/drug therapy; Double-Blind Method

• Source: Contemporary clinical trials, vol. 147, pp. 107708

تفاصيل العنوان

Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.

• Authors : Luke, J.J.; Long, G.V.; Robert, C.

Subjects: Humans; Antibodies; Monoclonal

• Source: European journal of cancer, vol. 207, pp. 114146

تفاصيل العنوان

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

• Authors : Shanu Modi; William Jacot; Toshinari Yamashita

Subjects: Antibodies; Monoclonal; Humanized / adverse effects

تفاصيل العنوان

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY):a randomised, controlled, open-label, platform trial

• Authors : Dhasmana, Devesh J; Horby, Peter W; Landray, Martin J

Subjects: Aged; 80 and over; Antibodies

• Source: RECOVERY Collaborative Group , Dhasmana , D J , Horby , P W & Landray , M J 2022 , ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled,

تفاصيل العنوان

Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study.

• Authors : Augustin, M.; Sator, P.G.; von Kiedrowski, R. ...

Subjects: Adult; Antibodies; Monoclonal/adverse effects

• Source: Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 10, pp. 1796-1804

تفاصيل العنوان

Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period

• Authors : Boccara, Franck; Caramelli, Bruno; Calmy, Alexandra

Subjects: info:eu-repo/classification/ddc/616; Antibodies; Monoclonal

• Source: ISSN: 0269-9370 ; AIDS, vol. 36, no. 5 (2022) p. 675-682.

تفاصيل العنوان

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels:A Randomized Controlled Trial

• Authors : Østergaard, Lars Jørgen

Subjects: Adenosine Monophosphate/adverse effects; Aged; Alanine/adverse effects

• Source: ACTIV-3/TICO Bamlanivimab Study Group & Østergaard , L J 2022 , ' Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen

تفاصيل العنوان

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.

• Authors : Canonica, Giorgio Walter; Harrison, Tim W; Chanez, Pascal

Subjects: asthma; asthma treatment; biologics

• Source: Allergy, 77 (1), 150-161 (2022)

تفاصيل العنوان

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.

• Authors : Láinez, Miguel J A; Schoenen, Jean; Stroud, Chad

Subjects: adverse events; calcitonin gene-related peptide monoclonal antibody; long-term exposure

• Source: Headache, 62 (1), 65 - 77 (2022-01)

تفاصيل العنوان

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

• Authors : Robert Motzer; Boris Alekseev; Sun-Young Rha

Subjects: Adult; Aged; 80 and over

تفاصيل العنوان